Obesity (Fen-Phen)

Aftermath of Fen-Phen Confirming Original Reports

Published in Women's Health Weekly, October 26th, 1998

While there are anecdotal reports of some former "fen-phen" patients getting worse and others getting better, all former fen-phen users still require continued medical monitoring, according to an expert in preventive medicine and nutrition.

Donald D. Hensrud, MD, from the Mayo Clinic, Rochester, Minnesota, discussed pharmacological treatment of obesity at the American Medical Association's 17th Annual Science Reporters' Conference on October 18, 1998.

Fenfluramine and dexfenfluramine (fenfluramine was combined with phentermine to produce the popular fen-phen diet drug) are the diet drugs that were pulled from the market in 1997 because of their...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1998-10-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry